METASTATIC COLORECTAL TREATMENT COSTS OF USING TARGETED DRUGS IN SECOND AND FURTHER LINES THERAPY
Author(s) -
N. А. Avxentyev,
E.V. Derkach,
E. Pyadushkina,
М. Д. Тер-Ованесов
Publication year - 2016
Publication title -
farmakoekonomika modern pharmacoeconomics and pharmacoepidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.177
H-Index - 3
eISSN - 2070-4933
pISSN - 2070-4909
DOI - 10.17749/2070-4909.2016.9.2.038-044
Subject(s) - regorafenib , panitumumab , cetuximab , medicine , colorectal cancer , kras , oncology , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom